SLF
UTHR icon

Sun Life Financial’s United Therapeutics UTHR Stock Holding History

Sun Life Financial’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,269
Closed -$181K – 577
2019
Q3 		$181K Buy
2,269
+290
+15% +$23.4K 0.05% 193
2019
Q2 		$154K Buy
1,979
+200
+11% +$18.7K 0.04% 203
2019
Q1 		$209K Buy
1,779
+10
+0.6% +$1.17K 0.05% 192
2018
Q4 		$193K Buy
1,769
+9
+0.5% +$1.04K 0.04% 203
2018
Q3 		$225K Buy
1,760
+11
+0.6% +$1.36K 0.04% 214
2018
Q2 		$198K Buy
+1,749
New +$192K 0.03% 226

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Sun Life Financial's UTHR Position: Q4 2019 in Review

Sun Life Financial sold out of United Therapeutics (UTHR) in Q4 2019, closing a stake of 2,269 shares — an estimated $181K sold.

Sun Life Financial first reported a position in UTHR in Q2 2018 and held it in 6 quarters. The position peaked at $225K in Q3 2018. 320 funds tracked by Wall St. Rank hold UTHR as of Q4 2019.

  • Sun Life Financial reported no remaining United Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Sun Life Financial sold 2,269 United Therapeutics shares in Q4 2019, an estimated $181K.
  • Sun Life Financial first reported a position in United Therapeutics in Q2 2018 and held it in 6 quarters.
  • Sun Life Financial's United Therapeutics position peaked at $225K in Q3 2018.
  • 320 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2019.

Based on Sun Life Financial's 13F filing for Q4 2019, filed 10 Feb 2020.